Navigation Links
Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
Date:10/13/2008

LOS ANGELES, Oct. 13 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on leading Australian biotechnology company Arana Therapeutics, (ASX: AAH; AIM: AAHx) and raised its target price to AU$1.65. "In our opinion, Arana differentiates itself from many competitors in the biotech space due to a strong cash position, a lucrative recurring revenue stream from IP licenses and a strong internal portfolio of products and proprietary technology platform. We strongly believe that Arana's current product pipeline has significant partnership potential and is bound to attract attention from large pharmaceutical companies. Over the past few years there has been a high level of interest from the large pharmaceutical companies in the human antibody sector, an area where Arana is a leader," said Ross Silver, Director of Research for Vista Partners. For more information and to download the free report, please visit the Vista Partners website at http://www.vistap.com and click on the "download research" icon located in the top right hand corner of the website.

About Vista Partners:

Vista Partners provides independent, equity research to institutional and individual investors, with a focus on publicly traded small capitalization companies. With offices in Los Angeles and San Francisco, Vista Partners is one of the fastest growing independently owned equity research firms. Vista Partners professional staff have backgrounds in finance, corporate communications and investment banking. More information is available at http://www.vistap.com.

About Arana Therapeutics:

Arana Therapeutics (ASX: AAH) is an international biopharmaceutical company formed through the merger of Peptech and EvoGenix in August 2007. The company uses superior technology to develop next generation drugs that will improve the lives of patients with inflammatory
'/>"/>

SOURCE Vista Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
3. Synvista Therapeutics to Present at the BIO InvestorForum 2007
4. Synvista Therapeutics to be Featured on Wallst.net
5. Provista Awards Agreement to Spheris
6. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
7. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
8. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
9. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
10. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
11. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... , Aug. 18, 2014 BioElectronics ... advanced consumer medical devices said that its ... interviewed by CEOLIVE.TV as part of its ... interview is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel ... explains to investors the unique advantages of ...
(Date:8/18/2014)... , August 18, 2014 ... Bioreactor Systems Market, By Application (Municipal Wastewater Treatment ... Flat Sheet and Multi Tubular), By Configuration (Internal/Submerged ... 2019", published by MarketsandMarkets, The market for membrane ... by 2019, growing at a CAGR of 15.28% ...
(Date:8/16/2014)... 2014 Firms in the ... and advisory services to businesses, government bodies and ... services are highly diverse as operators assist a ... from geological and geophysical consulting services to risk ... past five years, the recovery of the Canadian ...
(Date:8/15/2014)... 2014 Actor Robin Williams’ suicide has ... NBC’s Today Show reports, someone commits suicide every 13 ... of depression from the outside in, I contend that ... underlying cause from the inside out,” says neuroscientist Cynde ... , “Some of the accounts of Williams’ suicide have ...
Breaking Biology Technology:BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 2Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 3Neurofeedback Helps Alleviate the Underlying Causes of Depression 2Neurofeedback Helps Alleviate the Underlying Causes of Depression 3
... DUBLIN, Calif., April 22 SuperGen Inc.,(Nasdaq: SUPG ... and commercialization of therapies for solid tumors and,hematological malignancies, ... webcast of its 3rd Annual Analyst Day beginning at ... ET (9:00 a.m. PT) on Tuesday,April 29, 2008., ...
... to Significantly Increase Company,s ... Presence in China, ... announced today that it will build a major new research and,development ... global expansion and commitment to establishing a,long-term presence in China., ...
... Sysmex America, Inc. today,announced the successful ... studies for its integrated hematology and A1C ... Sysmex HST-N hematology,automation platform and the Bio-Rad ... automated diabetes testing in a random access,setting. ...
Cached Biology Technology:Genzyme to Build New R&D Center in Beijing 2Genzyme to Build New R&D Center in Beijing 3Genzyme to Build New R&D Center in Beijing 4Genzyme to Build New R&D Center in Beijing 5Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 2Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 3Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution 4
(Date:8/19/2014)... Scientists at the Houston Methodist Research Institute have figured ... using a pipette -- a common laboratory tool that,s ... preliminary test results in a recent issue of the ... "Studying single cells and their unique functions has become ... faculty member Lidong Qin, Ph.D., the project,s principal investigator. ...
(Date:8/19/2014)... of fizzy soda knows that bubbles can throw tiny ... wide industrial applications, Princeton researchers have demonstrated that the ... as well. , "It is well known that bursting ... fascinated, to discover that when we covered the water ... into the water," said Howard Stone, the Donald R. ...
(Date:8/19/2014)... humans and animals in a number of ways. They ... to regrow entire organs. After being struck by lightning, ... crown. But there is one major downside to life ... the habitats in which they live and therefore completely ... this dilemma, plants have developed mechanisms that enable them ...
Breaking Biology News(10 mins):Moving single cells around -- accurately and cheaply 2Bubbling down: Discovery suggests surprising uses for common bubbles 2Bubbling down: Discovery suggests surprising uses for common bubbles 3How steroid hormones enable plants to grow 2
... ... Biometrics, ATLANTA, July ... announced today that,it has reached an agreement with TimeForge, a provider ... the terms of this agreement, TimeForge will be providing its,customers with ...
... , Researchers in Japan and Canada have discovered ... inside human cells sometimes too well. The breakthrough has ... fibrosis (CF) and some other hereditary diseases, the researchers say. ... Science . Dr. Kazahiro Nagata and colleagues at Kyoto ...
... from the human use of fossil fuels, the world,s seas ... system. The chemical balance of the sea has long been ... the sea,s surface water has gone down by 0.1, or ... a century ago. Jon Havenhand and Michael Thorndyke, researchers at ...
Cached Biology News:M2SYS Technology Selected by TimeForge to Integrate Fingerprint Software 2Researchers discover cell's 'quality control' mechanism 2Acidification of the sea hampers reproduction of marine species 2
Mouse monoclonal [N7519] to NR0B2 ( Abpromise for all tested applications). Antigen: E.coli expressed recombinant full length protein (Human) NR0B2 Entrez Gene ID: 8431 Swiss Protein ID: ...
Rabbit polyclonal to BCA1 ( Abpromise for all tested applications). Antigen: Generated using E.coli expressed mouse BCA1. Entrez GeneID: 10563 SWISS Protein ID: O43927...
PKC Sampler Kit 10 mu g each...
Purified anti-SOCS3...
Biology Products: